Suppr超能文献

通过被动免疫接种预防细菌性超抗原葡萄球菌肠毒素B

Protection against bacterial superantigen staphylococcal enterotoxin B by passive vaccination.

作者信息

LeClaire Ross D, Hunt Robert E, Bavari Sina

机构信息

U.S. Army Medical Research Institute of Infectious Diseases, Frederick, Maryland 21702-5011, USA.

出版信息

Infect Immun. 2002 May;70(5):2278-81. doi: 10.1128/IAI.70.5.2278-2281.2002.

Abstract

We investigated the ability of two overlapping fragments of staphylococcal enterotoxin B (SEB), which encompass the whole toxin, to induce protection and also examined if passive transfer of chicken anti-SEB antibodies raised against the holotoxin could protect rhesus monkeys against aerosolized SEB. Although both fragments of SEB were highly immunogenic, the fragments failed to protect mice whether they were injected separately or injected together. Passive transfer of antibody generated in chickens (immunoglobulin Y [IgY]) against the whole toxin suppressed cytokine responses and was protective in mice. All rhesus monkeys treated with the IgY specific for SEB up to 4 h after challenge survived lethal SEB aerosol exposure. These findings suggest that large fragments of SEB may not be ideal for productive vaccination, but passive transfer of SEB-specific antibodies protects nonhuman primates against lethal aerosol challenge. Thus, antibodies raised in chickens against the holotoxin may have potential therapeutic value within a therapeutic window of opportunity after SEB encounter.

摘要

我们研究了葡萄球菌肠毒素B(SEB)的两个重叠片段(这两个片段涵盖了整个毒素)诱导保护作用的能力,还检测了用针对全毒素产生的鸡抗SEB抗体进行被动转移是否能保护恒河猴免受雾化SEB的侵害。尽管SEB的两个片段都具有高度免疫原性,但无论单独注射还是一起注射,这些片段都无法保护小鼠。鸡产生的针对全毒素的抗体(免疫球蛋白Y [IgY])的被动转移可抑制细胞因子反应,并且对小鼠具有保护作用。在攻击后长达4小时用针对SEB的IgY治疗的所有恒河猴在致死性SEB气溶胶暴露中均存活。这些发现表明,SEB的大片段可能不是有效疫苗接种的理想选择,但SEB特异性抗体的被动转移可保护非人灵长类动物免受致死性气溶胶攻击。因此,鸡针对全毒素产生的抗体在接触SEB后的治疗机会窗内可能具有潜在的治疗价值。

相似文献

1
Protection against bacterial superantigen staphylococcal enterotoxin B by passive vaccination.
Infect Immun. 2002 May;70(5):2278-81. doi: 10.1128/IAI.70.5.2278-2281.2002.
10

引用本文的文献

1
Passive Immunotherapy of Cynomolgus Monkeys with Anti-Rotavirus IgY.
Pharmaceutics. 2024 Aug 30;16(9):1149. doi: 10.3390/pharmaceutics16091149.
3
IgY antibodies: The promising potential to overcome antibiotic resistance.
Front Immunol. 2023 Jan 20;14:1065353. doi: 10.3389/fimmu.2023.1065353. eCollection 2023.
4
IgY Targeting Bacterial Quorum-Sensing Molecules in Implant-Associated Infections.
Molecules. 2020 Sep 3;25(17):4027. doi: 10.3390/molecules25174027.
5
Epidemiological and Clinical Evidence for the Role of Toxins in Human Disease.
Toxins (Basel). 2020 Jun 19;12(6):408. doi: 10.3390/toxins12060408.
6
Determining the immunological characteristics of a novel human monoclonal antibody developed against staphylococcal enterotoxin B.
Hum Vaccin Immunother. 2020 Jul 2;16(7):1708-1718. doi: 10.1080/21645515.2020.1744362. Epub 2020 Apr 10.
7
Egg yolk antibodies (IgY) and their applications in human and veterinary health: A review.
Int Immunopharmacol. 2019 Aug;73:293-303. doi: 10.1016/j.intimp.2019.05.015. Epub 2019 May 22.
8
Effects of specific egg yolk immunoglobulin on pan-drug-resistant Acinetobacter baumannii.
Biomed Pharmacother. 2017 Nov;95:1734-1742. doi: 10.1016/j.biopha.2017.09.112. Epub 2017 Oct 6.
9
An Update on Clinical Burden, Diagnostic Tools, and Therapeutic Options of .
Infect Dis (Auckl). 2017 May 22;10:1179916117703999. doi: 10.1177/1179916117703999. eCollection 2017.
10
IgY antibodies in human nutrition for disease prevention.
Nutr J. 2015 Oct 20;14:109. doi: 10.1186/s12937-015-0067-3.

本文引用的文献

2
Inhibition of bacterial superantigens by peptides and antibodies.
Infect Immun. 2001 Feb;69(2):875-84. doi: 10.1128/IAI.69.2.875-884.2001.
3
Human antibodies to bacterial superantigens and their ability to inhibit T-cell activation and lethality.
Antimicrob Agents Chemother. 2001 Feb;45(2):460-3. doi: 10.1128/AAC.45.2.460-463.2001.
5
Superantigens - powerful modifiers of the immune system.
Mol Med Today. 2000 Mar;6(3):125-32. doi: 10.1016/s1357-4310(99)01657-3.
7
Development of engineered vaccines effective against structurally related bacterial superantigens.
Vaccine. 1998 Nov;16(19):1857-64. doi: 10.1016/s0264-410x(98)00176-5.
8
The clinical significance of T-cell superantigens.
Trends Microbiol. 1998 Feb;6(2):61-5. doi: 10.1016/S0966-842X(97)01193-1.
9
Bacterial superantigens in human disease: structure, function and diversity.
Trends Microbiol. 1995 Dec;3(12):463-8. doi: 10.1016/s0966-842x(00)89011-3.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验